SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-09-18 14:39
Tx date 2019-09-13
$KLY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$26,306
+526,120 vol
$0.05 each
526,120
Filed 2019-09-18 14:38
Tx date 2016-12-30
$KLY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-09-18 14:38
Tx date 2019-09-13
$KLY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$26,306
+526,120 vol
$0.05 each
590,561
Filed 2019-06-24 10:03
Tx date 2019-06-19
$KLY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+68,698 vol
4,209,781
Filed 2019-01-28
Tx date 2019-01-25
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+1,129,318 vol
4,141,083
Filed 2018-09-27
Tx date 2018-09-24
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+1,262,475 vol
3,011,765
Filed 2018-03-16
Tx date 2018-02-15
$RMSP
RMR Science Technologies Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-15
$RMSP
RMR Science Technologies Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+275,000 vol
275,000
Filed 2018-02-16
Tx date 2018-02-15
$
RMR Science Technologies Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-02-16
Tx date 2018-02-15
$
RMR Science Technologies Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$60,000
+1,200,000 vol
$0.05 each
1,200,000
Filed 2018-01-31
Tx date 2018-01-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+326,000 vol
1,749,290
Filed 2017-12-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+304,764 vol
Filed 2017-12-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust II (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+304,764 vol
Filed 2017-12-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust II (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+308,764 vol
308,764
Filed 2017-12-06
Tx date 2017-10-08
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+1,022,610 vol
1,423,290
Filed 2017-12-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+308,764 vol
308,764
Filed 2017-04-28
Tx date 2011-07-26
$BTI
biOasis Technologies Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2017-04-28
Tx date 2017-04-24
$BTI
biOasis Technologies Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Rights
56 - Grant of rights

+30,000 vol
30,000
Filed 2017-04-28
Tx date 2017-04-24
$BTI
biOasis Technologies Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+125,000 vol
800,000
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+64,441 vol
64,441
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+304,764 vol
304,764
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust II (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust II (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+304,764 vol
304,764
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+193,808 vol
193,808
Filed 2017-01-06
Tx date 2016-12-30
$KALY
Kalytera Therapeutics, Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+206,872 vol
400,680
Filed 2016-04-14
Tx date 2016-04-10
$BTI
biOasis Technologies Inc.
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
675,000